Literature DB >> 10882382

Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus.

D E Selley1, C C Cao, Q Liu, S R Childers.   

Abstract

1. Sodium ions inhibit spontaneous G(i)/G(o)-coupled receptor activity and promote agonist-induced responses in vitro. The effects of sodium on the relative efficacy of opioid agonists for G-protein activation was measured by guanosine-5'-O-(gamma-(35)S)-triphosphate ([(35)S]-GTPgammaS) binding in membranes from two mu-opioid receptor-containing systems: CHO cells stably transfected with mouse mureceptors (mMOR-CHO cells) and rat thalamus. 2. NaCl inhibited basal [(35)S]-GTPgammaS binding in both systems, and this effect was partially mimicked by KCl. In mMOR-CHO membranes, net [(35)S]-GTPgammaS binding stimulated by partial but not full agonists was inhibited by NaCl with a potency that was inversely proportional to agonist efficacy. Monovalent cations were required for agonist-stimulated [(35)S]-GTPgammaS binding in this system, and increasing NaCl concentrations magnified relative efficacy differences among agonists. 3. In thalamic membranes, which contain a lower receptor:G-protein ratio than mMOR-CHO cells, similar monovalent cation effects were observed, with two exceptions: (1) [(35)S]-GTPgammaS binding stimulated by both full and partial agonists was inhibited by NaCl; and (2) monovalent cations were not required to observe agonist-stimulated [(35)S]-GTPgammaS binding. 4. Basal [(35)S]-GTPgammaS binding stimulated by the absence of monovalent cations resembled that of agonist-stimulated binding and was blocked by pretreatment of mMOR-CHO cells with pertussis toxin. 5. These results indicate that sodium inhibits spontaneous and agonist-occupied mu receptor-mediated G-protein activation in a manner inversely proportional to the efficacy of the agonist, and that spontaneous mu receptor activity and the relative efficacy of partial agonists acting at these receptors are both increased by increases in the stoichiometric ratio of receptors:G-proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882382      PMCID: PMC1572152          DOI: 10.1038/sj.bjp.0703382

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Studies on nucleotide and receptor regulation of Gi proteins: effects of pertussis toxin.

Authors:  T Sunyer; B Monastirsky; J Codina; L Birnbaumer
Journal:  Mol Endocrinol       Date:  1989-07

2.  Interaction of full and partial agonists of the A1 adenosine receptor with receptor/G protein complexes in rat brain membranes.

Authors:  A Lorenzen; L Guerra; H Vogt; U Schwabe
Journal:  Mol Pharmacol       Date:  1996-05       Impact factor: 4.436

3.  Analysis of inverse agonism at the delta opioid receptor after expression in Rat 1 fibroblasts.

Authors:  I Mullaney; I C Carr; G Milligan
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

4.  Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts alpha 2A-adrenergic receptor sensitivity to allosteric modulation by monovalent cations and fully effective receptor/G-protein coupling.

Authors:  B P Ceresa; L E Limbird
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

5.  Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality.

Authors:  M Herkenham; C B Pert
Journal:  J Neurosci       Date:  1982-08       Impact factor: 6.167

6.  Evaluation of a series of N-alkyl benzomorphans in cell lines expressing transfected delta- and mu-opioid receptors.

Authors:  M E Abood; M A Noel; R C Carter; L S Harris
Journal:  Biochem Pharmacol       Date:  1995-09-07       Impact factor: 5.858

7.  Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.

Authors:  J R Traynor; S R Nahorski
Journal:  Mol Pharmacol       Date:  1995-04       Impact factor: 4.436

8.  Regulation of basal adenylate cyclase activity in neuroblastoma x glioma hybrid, NG108-15, cells transfected to express the human beta 2 adrenoceptor: evidence for empty receptor stimulation of the adenylate cyclase cascade.

Authors:  E J Adie; G Milligan
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

9.  Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells.

Authors:  V C Yu; W Sadée
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

10.  Characterization of the murine mu opioid receptor gene.

Authors:  D L Kaufman; D E Keith; B Anton; J Tian; K Magendzo; D Newman; T H Tran; D S Lee; C Wen; Y R Xia
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

View more
  25 in total

1.  Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.

Authors:  Mark A Smith; Keith A Gordon; Christopher K Craig; Paul A Bryant; M Eric Ferguson; Adam M French; Jason D Gray; Jacob M McClean; Jonathan C Tetirick
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

Review 2.  Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors.

Authors:  Philip G Strange
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D₂ and D₃ Receptors.

Authors:  Maarten E A Reith; Aloke K Dutta; Dana E Selley; Juan Zhen; Tamara Antonio; Joanna C Jacob; David K Grandy
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

4.  Mechanisms of inverse agonist action at D2 dopamine receptors.

Authors:  David J Roberts; Philip G Strange
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

5.  Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.

Authors:  Kathryn E Livingston; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 6.  Modulation of GPCRs by monovalent cations and anions.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Erich H Schneider; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-30       Impact factor: 3.000

7.  Mexneurin is a novel precursor of peptides in the central nervous system of rodents.

Authors:  Maura E Matus-Ortega; Philippe Leff Gelman; Juan C Calva-Nieves; Anabel Flores-Zamora; Alberto Salazar-Juárez; Carlos-Alejandro Torner-Aguilar; Gerardo Gamba; Paola De Los Heros; Bonnie Peng; John E Pintar; Heinrich S Gompf; Charles N Allen; Benito Antón-Palma
Journal:  FEBS Lett       Date:  2017-06-01       Impact factor: 4.124

8.  Consensus 3D model of μ-opioid receptor ligand efficacy based on a quantitative Conformationally Sampled Pharmacophore.

Authors:  Jihyun Shim; Andrew Coop; Alexander D MacKerell
Journal:  J Phys Chem B       Date:  2011-05-12       Impact factor: 2.991

9.  Allosteric sodium in class A GPCR signaling.

Authors:  Vsevolod Katritch; Gustavo Fenalti; Enrique E Abola; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Biochem Sci       Date:  2014-04-21       Impact factor: 13.807

10.  Molecular control of δ-opioid receptor signalling.

Authors:  Gustavo Fenalti; Patrick M Giguere; Vsevolod Katritch; Xi-Ping Huang; Aaron A Thompson; Vadim Cherezov; Bryan L Roth; Raymond C Stevens
Journal:  Nature       Date:  2014-01-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.